EAACI Congress 2024 Back

31 May - 03 June 2024 Valencia, Spain

Stefan Zielen

Germany

Stefan Zielen

Prof Stefan Zielen was the head of the Division on Allergology, Pneumology, and Cystic fibrosis at the Department of Pediatrics at the Goethe-University for 22 years. Prof. Zielen is an expert in asthma, rare lung diseases, and allergic diseases. (www.medaimun.de).

Sessions

Friday 31 May

12:36 - 12:48 Impact of a 3-tree sublingual immunotherapy liquid formulation in birch family pollen-allergic patients on prevention of disease progression and/or asthma onset

15:36 - 15:48 Epigenetic regulation of exercise-induced bronchoconstriction in patients with and without allergy

Saturday 1 Jun

Slow crippling lung disease in Ataxia telangiectasia: lung function and CT findings

Sunday 2 Jun

Meta-analysis of primary endpoint of PQ Grass field studies with optimized dose and treatment regimen of PQ Grass

Positive outcome of the pivotal Phase III study with PQ Grass, a modified grass allergen subcutaneous immunotherapy (SCIT) product using MicroCrystalline Tyrosine and Monophosphoryl Lipid A as adjuvant system

Secondary endpoint profile is strongly supportive for the positive outcome of the pivotal Phase III study with PQ Grass

SAT3-3 Allergy Therapeutics - Setting a new standard for grass subcutaneous immunotherapy Sponsored Sessions Alicante , Channel Alicante

Welcome and Introduction

Q&A session

EAACI Congress 2024 Back

Sessions

Share this pen